Vitamin B12 (Cobalamin) for Anemia

Research suggests that vitamin B12 deficiency is a well-established cause of macrocytic and megaloblastic anemia, as well as pernicious anemia, and that correcting this deficiency through supplementation is central to treating these conditions — a conclusion supported across multiple reviews and clinical guidelines. The available evidence, which includes narrative reviews, clinical practice guidelines, and smaller observational studies rather than large-scale randomized controlled trials specifically on B12 and anemia outcomes, generally supports the efficacy of B12 repletion, with one 2003 review notably indicating that oral supplementation may be as effective as injections even in malabsorption conditions like pernicious anemia. However, the evidence also carries meaningful caveats: reviews from 2021 and 2016 highlight that standard serum B12 testing frequently misses true deficiency, that symptoms can overlap with more serious blood disorders, and that some neurological damage from prolonged deficiency may be irreversible even after treatment begins. Taken together, the research points to B12 repletion as strongly indicated for deficiency-related anemia, while underscoring that accurate diagnosis remains a persistent clinical challenge and that the field may benefit from more rigorously designed intervention trials.